Key result
Angiotensin II infusion prolongs isovolumic relaxation time by ~12 ms vs placebo.
Why the study?
The effects of angiotensin II and aldosterone on diastolic function in normal humans were not well characterized in vivo.
Do infusions of angiotensin II and aldosterone affect diastolic function and systemic haemodynamics in normal male subjects?
RCT (n=10)
Do infusions of angiotensin II and aldosterone affect diastolic function and systemic haemodynamics in normal male subjects?
Angiotensin II impairs left ventricular diastolic filling independently of its effect on aldosterone release, even at sub-pressor concentrations.
Answers are grounded in this paper and cite their sources.
Ang II impairs LV diastolic filling independently of aldosterone even at sub-pressor doses in healthy men; extends evidence for direct RAAS effects on relaxation.
Doppler echocardiographic indices of diastolic function and systemic haemodynamics were studied in response to infusions of angiotensin II (1, 2, 5 and 10 ng min-1 kg-1), D-aldosterone (2, 4, 10 and 20 ng min-1 kg-1) and placebo [0.9% (w/v) NaCl] in ten normal male subjects. 2. Dose-related increases in systolic and diastolic blood pressure were observed with angiotensin II infusion at rates of 2 ng min-1 kg-1 and above, whereas no changes in blood pressure occurred with D-aldosterone. No changes in aortic stroke distance or heart rate were seen with either angiotensin II or aldosterone infusion. 3. Compared with placebo, angiotensin II infusion produced a dose-related prolongation of the isovolumic relaxation time [mean and 95% confidence intervals 12.0 (8.2-15.8) ms, P < 0.001] at 10 ng min-1 kg-1, and a significant reduction in the ratio between early and late transmitral flow velocity integrals at 2 ng min-1 kg-1, [-0.84 (-1.63 to -0.05), P < 0.05] and 5 ng min-1 kg-1 [-0.76 (-1.47 to -0.05), P < 0.05]. No changes in Doppler echocardiographic indices of diastolic function were observed with D-aldosterone infusion. 4. These data suggest that angiotensin II, even at a sub-pressor concentration, produces an impairment of left ventricular diastolic filling, which occurs independently of its effect on aldosterone release.
No takes yet. Share an insight, caveat, or question.
Clarkson et al. (1994) conducted an RCT in Healthy (n=10). Angiotensin II and D-aldosterone vs. Placebo [0.9% (w/v) NaCl] was evaluated on Isovolumic relaxation time (MD 12.0 ms, 95% CI 8.2-15.8, p=< 0.001). Angiotensin II infusion produced a dose-related prolongation of isovolumic relaxation time compared with placebo.
Synapse has enriched 10 related papers. Consider them for comparative context: